Ivarmacitinib
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Ivarmacitinib, covering 2024-12-12 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Switching to Ivarmacitinib in Patients With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to Interleukin-4 Receptor Alpha(IL-4Rα) Inhibitors: A Prospective, Multicenter, Real-World Study [NA]